Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Additional Paid In Capital
Mizuho Medy Co Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Additional Paid In Capital
¥274m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Additional Paid In Capital
¥51.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Olympus Corp
TSE:7733
|
Additional Paid In Capital
¥92.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Sysmex Corp
TSE:6869
|
Additional Paid In Capital
¥20.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Additional Paid In Capital
¥9.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
JEOL Ltd
TSE:6951
|
Additional Paid In Capital
¥21.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
274m
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Additional Paid In Capital amounts to 274m JPY.
What is Mizuho Medy Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
0%
Over the last year, the Additional Paid In Capital growth was 0%.
You don't have any saved screeners yet